Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Significant Increase in Short Interest

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 318,100 shares, an increase of 122.4% from the April 30th total of 143,000 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 1,521,900 shares, the days-to-cover ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on BAYRY shares. Hsbc Global Res raised shares of Bayer Aktiengesellschaft to a "hold" rating in a research note on Monday, April 28th. Wall Street Zen raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research note on Saturday.

Bayer Aktiengesellschaft Price Performance

Shares of Bayer Aktiengesellschaft stock remained flat at $7.06 during trading hours on Friday. 460,382 shares of the stock traded hands, compared to its average volume of 830,465. Bayer Aktiengesellschaft has a 52 week low of $4.79 and a 52 week high of $8.58. The firm has a fifty day moving average price of $6.33 and a two-hundred day moving average price of $5.80. The firm has a market cap of $27.74 billion, a P/E ratio of -27.15 and a beta of 0.84. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported $0.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.63 by $0.02. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. The firm had revenue of $15.27 billion for the quarter, compared to the consensus estimate of $13.39 billion. On average, sell-side analysts anticipate that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Increases Dividend

The company also recently declared a dividend, which was paid on Monday, May 12th. Investors of record on Wednesday, April 30th were paid a dividend of $0.0224 per share. This is an increase from Bayer Aktiengesellschaft's previous dividend of $0.02. The ex-dividend date was Tuesday, April 29th. This represents a yield of 0.38%. Bayer Aktiengesellschaft's payout ratio is -2.17%.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.